Effect of the Bioprotective Properties of Lactic Acid Bacteria Strains on Quality and Safety of Feta Cheese Stored under Different Conditions.

Autor: Doukaki A; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Papadopoulou OS; Institute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, S. Venizelou 1, 14123 Lycovrissi, Greece., Baraki A; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Siapka M; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Ntalakas I; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Tzoumkas I; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Papadimitriou K; Laboratory of Food Quality Control and Hygiene, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Tassou C; Institute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, S. Venizelou 1, 14123 Lycovrissi, Greece., Skandamis P; Laboratory of Food Quality Control and Hygiene, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Nychas GJ; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece., Chorianopoulos N; Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece.

Publikováno v: Microorganisms [Microorganisms] 2024 Sep 10; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 10.

Considering equity in priority setting using transmission models: recommendations and data needs

Autor: Quaife, M., Medley, G.F., Jit, M., Drake, T., Asaria, M., van Baal, P., Baltussen, R., Bollinger, L., Bozzani, F., Brady, O., Broekhuizen, H., Chalkidou, K., Chi, Y.L., Dowdy, D.W., Griffin, S., Haghparast-Bidgoli, H., Hallett, T., Hauck, K., Hollingsworth, T.D., McQuaid, C.F., Menzies, N.A., Merritt, M.W., Mirelman, A., Morton, A., Ruiz, F.J., Siapka, M., Skordis, J., Tediosi, F., Walker, P., White, R.G., Winskill, P., Vassall, A., Gomez, G.B.

Publikováno v: Epidemics, 41
Epidemics, 41:100648. Elsevier
Epidemics 41 (2022)

Objectives Disease transmission models are used in impact assessment and economic evaluations of infectious disease prevention and treatment strategies, prominently so in the COVID-19 response. These models rarely consider dimensions of equity relati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::238feb731f1bec83aececabc4216acdd
https://doi.org/10.1016/j.epidem.2022.100648

Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis.

Autor: Onwuchekwa C; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Moreo LM; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Menon S; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Machado B; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Curcio D; Pfizer Vaccine, Ireland., Kalina W; Pfizer Vaccine, Ireland., Atwell JE; Pfizer Vaccine, Ireland., Gessner BD; Pfizer Vaccine, Ireland., Siapka M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.; Impact Epilysis, Thessaloniki, Greece., Agarwal N; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Rubbrecht M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Nair H; Usher Institute, University of Edinburgh, Edinburgh, United Kingdom., Rozenbaum M; Pfizer Inc, Capelle aan den Ijssel, The Netherlands., Aponte-Torres Z; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Vroling H; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Begier E; Pfizer Vaccine, Ireland.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Jul 14; Vol. 228 (2), pp. 173-184.

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.

Autor: Gomez GB; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK gabriela.gomez@lshtm.ac.uk.; Modelling, Epidemiology and Data Science Department, Sanofi Pasteur, Lyon, France., Siapka M; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Impact Epilysis, Thessaloniki, Greece., Conradie F; Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Ndjeka N; National TB Programme, South Africa Department of Health, Pretoria, Gauteng, South Africa., Garfin AMC; National Tuberculosis Control Program, Bureau of Disease Prevention and Control, Department of Health, Manila, The Philippines., Lomtadze N; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Avaliani Z; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Kiria N; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Malhotra S; TB Alliance, New York, New York, USA.; Global Access, International AIDS Vaccine Initiative (IAVI), New York, New York, USA., Cook-Scalise S; TB Alliance, New York, New York, USA.; TB Division, USAID, Washington, DC, USA., Juneja S; TB Alliance, New York, New York, USA., Everitt D; TB Alliance, New York, New York, USA., Spigelman M; TB Alliance, New York, New York, USA., Vassall A; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Publikováno v: BMJ open [BMJ Open] 2021 Dec 03; Vol. 11 (12), pp. e051521. Date of Electronic Publication: 2021 Dec 03.

Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.

Autor: Evans, Denise¹ (AUTHOR) devans@heroza.org, Hirasen, Kamban^1,2 (AUTHOR), Ramushu, Clive¹ (AUTHOR), Long, Lawrence^1,3 (AUTHOR), Sinanovic, Edina² (AUTHOR), Conradie, Francesca⁴ (AUTHOR), Howell, Pauline⁴ (AUTHOR), Padanilam, Xavier⁵ (AUTHOR), Ferreira, Hannetjie⁶ (AUTHOR), Variaiva, Ebrahim⁶ (AUTHOR), Rajaram, Shakira⁴ (AUTHOR), Gupta, Aastha⁷ (AUTHOR), Juneja, Sandeep⁷ (AUTHOR), Ndjeka, Norbert⁸ (AUTHOR)

Publikováno v: PLoS ONE. 10/21/2024, Vol. 19 Issue 10, p1-19. 19p.